UPDATE
: Monday, December 16, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Crystal Genomics confirms efficacy of epigenetics-based pulmonary fibrosis treatment
by Lee Han-soo
2019-10-01 11:21
‘Merck Korea unilaterally lays off employees’
by Kim Yun-mi
2019-10-01 11:09
Allergan to compensate breast implant recipients for damage
by Lee Hye-seon
2019-09-30 15:33
Ranitidine recall taking heavy toll on pharmaceuticals
by Jeong Sae-im
2019-09-30 15:16
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
by Lee Hye-seon
2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
by Lee Han-soo
2019-09-27 15:11
Genexine sets up joint firm in Thailand
by Lee Han-soo
2019-09-26 17:00
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
by Lee Han-soo
2019-09-26 15:39
Pfizer’s leukemia therapy Besponsa to get insurance benefit
by Kim Yun-mi
2019-09-26 11:26
'Xtandi emerges as convenient treatment option for prostate cancer patients'
by Lee Han-soo
2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
by Lee Han-soo
2019-09-25 11:18
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
by Lee Han-soo
2019-09-24 18:08
Qurient enrolls patients for trials of atopy treatment
by Lee Han-soo
2019-09-24 17:00
Hanmi’s US partner to unveil results of anticancer drug study
by Lee Han-soo
2019-09-24 17:00
Why using end-to-end services should be part of a drug product strategy
by Lee Han-soo
2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
by Lee Han-soo
2019-09-24 16:38
Hwail, SupexBNP wins patent for neutropenia treatment in US
by Lee Han-soo
2019-09-23 22:34
Drug firms uncertain about pricing of quadrivalent flu vaccines
by Jeong Sae-im
2019-09-23 14:52
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
by Lee Han-soo
2019-09-23 13:28
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
by Kim Yun-mi
2019-09-23 11:45
-
1
2
3
4
5
6
7
8
9
10
다음
-
[News Focus] 'You, too, can use millions of patients’ data for research'
Celltrion secures 11 synthetic drugs to advance to US market
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar
Patient cries for stem cell therapy approval to stop heart necrosis
[News Focus] 'You, too, can use millions of patients’ data for research'
Celltrion secures 11 synthetic drugs to advance to US market
Dong-A, Meiji Seika to conduct P1 trial for Stelara biosimilar
Patient cries for stem cell therapy approval to stop heart necrosis
여백
Most viewed
1
ABL Bio unveils new bispecific antibody at US meet
2
Aprogen, 1st Korean biotech firm to win unicorn status
3
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
4
Curexo launches 1st locally developed spine surgery robot
5
Samsung execs get jail term for destroying evidence
6
Samsung Bioepis to start P3 trial for Ontruzant in China
7
Eli Lilly Korea launches migraine prevention drug
8
Korean physician 1st Asian to do 1,000 robotic myomectomy surgeries
9
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
10
SK Bioscience's chickenpox vaccine world's 2nd to get WHO’s PQ certification
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top